LabGenomics Balance Sheet Health
Financial Health criteria checks 3/6
LabGenomics has a total shareholder equity of ₩222.7B and total debt of ₩46.2B, which brings its debt-to-equity ratio to 20.7%. Its total assets and total liabilities are ₩307.5B and ₩84.7B respectively.
Key information
20.7%
Debt to equity ratio
₩46.19b
Debt
Interest coverage ratio | n/a |
Cash | ₩107.89b |
Equity | ₩222.75b |
Total liabilities | ₩84.71b |
Total assets | ₩307.45b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A084650's short term assets (₩150.9B) exceed its short term liabilities (₩82.0B).
Long Term Liabilities: A084650's short term assets (₩150.9B) exceed its long term liabilities (₩2.7B).
Debt to Equity History and Analysis
Debt Level: A084650 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A084650's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A084650's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A084650's interest payments on its debt are well covered by EBIT.